Policy / Pricing FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development FDASince publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternativesPolicy / PricingRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) FDA Since publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternatives Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: 221: An Interview With Dutch Neurologist Ewout Groen of SMA EuropeNext: Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026